All Type of News
Multinational firms’ R&D spending drops 2.2% in 2011
Multinational drug firms slightly cut back their spending on research and developing (R&D) last year, dampened by economic jitters stemming from a global slowdown, data showed Wednesday.
The combined R&D spending o...
Hanmi boosting R&D spending
Hanmi Pharmaceutical has been spending more on 20 research and development (R&D) projects to strengthen its technology leadership.
The company spent 41.7 billion won on R&D in the first half of this year, which acc...
Government to support CJ Pharma’s diabetes drug development
The pharmaceutical unit of CJ Cheil Jedang, the country’s largest food manufacturer, said Wednesday it plans to carry out local Phase I clinical trials for its new combination diabetes drug candidate as part of a gove...
Drug makers see their cash reserves piling up
A growing number of pharmaceutical firms piled up in the first half of this year, as they refrained from investing amid the worsening business slump, , data showed Tuesday.
The average cash reserve ratio of 52 list...
More pill prescriptions found in clinics
Patients were prescribed with an average of 3.84 pills per hospital visit last year, the Health Insurance Review and Assessment Service said Monday.
However, the drug agency found that doctors in clinics prescribed...
Government to readjust prices of 10 vaccines
The government plans to readjust the prices of ten essential vaccines to be used for hospitals and clinics, the Ministry of Health and Welfare said Tuesday.
The measures is aimed at rationalizing the vaccine prices...
Ahngook signs drug deal with Takeda Korea
Ahngook Pharmaceutical said Tuesday it has signed an agreement with Takeda Korea in a move to exclusively distribute the latter’s Zycomb nasal spray solution here.
Zycomb is a combination medicinal product consisti...
Lee Jong-kap named managing director of Guerbet KoreaLee Jong-kap has been named managing director of Guerbet Korea, the company said Tuesday.
Lee, 50, will be solely responsible for marketing all contrast media to be used in M...
|
New service fees to rise
The government plans to impose new screening service charges to screen the approval of new drugs beforehand, the Korea Food and Drug Administration said Monday.
Under the plan, the service fee for review of safety ...
KPMA to toughen regulations on drug price dumping
The Korea Pharmaceutical Manufacturers Association (KPMA) Monday reaffirmed to toughen the punishment on those member companies who violate the rule in hospital biddings to create more fair business atmosphere.
The...
